Showing 1 - 8 results of 8 for search '(( mid-range selection function ) OR ( mid-range detection function ))', query time: 0.15s Refine Results
  1. 1

    Mid-Range Inhomogeneity of Eukaryotic Genomes by Larisa Fedorova, Alexei Fedorov

    Published 2011-01-01
    “…These regions are associated with unusual DNA conformations and/or particular DNA properties. In particular, mid-range inhomogeneous regions have complex arrangements relative to each other and to specific genomic sites, such as centromeres, telomeres, and promoters, pointing to their important role in genomic functioning and organization.…”
    Get full text
    Article
  2. 2
  3. 3

    Myocardial mechanical function measured by cardiovascular magnetic resonance in patients with heart failure by Yufan Gao, Boxin Li, Yanhe Ma, Shuo Liang, Anhong Yu, Hong Zhang, Zhigang Guo

    Published 2024-01-01
    “…ABSTRACT: Background: Strain analysis offers a valuable tool to assess myocardial mechanics, allowing for the detection of impairments in heart function. This study aims to evaluate the pattern of myocardial strain in patients with heart failure (HF). …”
    Get full text
    Article
  4. 4
  5. 5

    ROLE OF GENDER SPECIFICS IN MYOCARDIAL REMODELLING, CARDIOVASCULAR COMPLICATIONS DEVELOPMENT AND EFFICACY OF PHARMACOTHERAPY IN HEART FAILURE PATIENTS AFTER CARDIAC SURGERY by Yu. V. Liskova, А. А. Stadnikov, S. P. Salikova

    Published 2017-12-01
    “…In HFpEF males there was decrease of EF with transition to “grey zone” by III functional class, and eccentric remodeling predominated with unchanged diastolic function. …”
    Get full text
    Article
  6. 6

    Correlation between mitral annular plane systolic excursion (MAPSE) at different degrees of ejection fraction in patients with diabetes mellitus by Muhammad Rido, Khalid Saleh, A. Makbul Aman, Syakib Bakri, Haerani Rasyid, Andi Alfian Zainuddin

    Published 2024-09-01
    “…Diabetic cardiomyopathy is characterized by myocardial structure and function abnormality in the absence of other cardiovascular risk factors. …”
    Get full text
    Article
  7. 7

    Differential Effects of Landiolol in Patients with Atrial Fibrillation and Atrial Tachycardia by Kengo Ayabe, Tomoyoshi Komiyama, Hiroyuki Takekawa, Honsa Kang, Yasuaki Tsumagari, Miwa Ito, Keiichi Ashikaga, Yoshisato Shibata

    Published 2024-10-01
    “…To this end, we evaluated the efficacy and safety of landiolol in managing tachycardiac AF and tachycardiac atrial flutter/AT in 44 patients with reduced left ventricular function. We found that while landiolol was effective in managing patients with AF and heart failure with a preserved or mid-range ejection fraction, however, it might be more challenging to control heart rate in patients with AT using a similar dosage of landiolol.…”
    Get full text
    Article
  8. 8

    Efficacy of angiotensin receptor neprilysin inhibitor for maintenance hemodialysis patients with different types of left ventricular ejection fraction heart failure by Jin-cong Li, Nan-hui Zhang, Lei Wang, Jun-meng Peng, Hui-hui Wang, Wen-hui Chen

    Published 2024-12-01
    “…Methods From June 1, 2022 to May 31, 2023, 155 MHD patients with concurrent HF continuously taking S/V for more than 3 months were selected. According to the level of LVEF, they were assigned into three groups of HF with reduced ejection fraction(HFrEF, n=41), HF with mid-range ejection fraction(HFmrEF, n=42) and HF with preserved ejection fraction(HFmrEF, n=2). …”
    Get full text
    Article